Basel, Switzerland (ots/PRNewswire) - - First Anti-Anaemia Product Offering Simple Once-Monthly Maintenance Treatment Roche announced today that the European Commission has approved its innovative drug MIRCERA to treat anaemia associated with chronic kidney disease (CKD). The approval of MIRCERA results in a single marketing authorisation with unified ...
San Diego (ots/PRNewswire) - Revenues US$2.33 Billion, Diluted EPS US$0.47 Pro Forma Revenues US$2.33 Billion, Diluted EPS US$0.55 Financial Guidance Increased for Fiscal 2007 QUALCOMM Incorporated (Nasdaq: QCOM) today announced record results for the third quarter of fiscal 2007 ended July 1, 2007. Total QUALCOMM (GAAP) Third Quarter Results Total QUALCOMM ...
Boehringer Ingelheim and Pfizer
Ingelheim, Germany (ots/PRNewswire) - - Patients to Benefit From Easy-to-Use Inhaler With Enhanced Drug Delivery Boehringer Ingelheim and Pfizer today announced successful completion of the approval process for authorisation to market SPIRIVA(R) Respimat(R) in the European Union for people with chronic obstructive pulmonary disease (COPD). This positive ...
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. 6-month report 23.07.2007 Key financial data for the second quarter and first six months of 2007 Unterpremstaetten, Austria (July 23, 2007) - austriamicrosystems (SWX: AMS), a leading global ...
Basel, Switzerland (ots/PRNewswire) - - First Medicine Shown to Extend Survival of Previously Untreated Patients Beyond One Year Roche announced today that the European Committee for Medicinal Products for Human Use (CHMP) has issued a positive recommendation for the first-line use of Avastin in the ...
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. 10.07.2007 - Experienced entrepreneur and investor as further large shareholder - Start through capital increase in cash - Strategic impact expected HAMBURG. July 10, 2007. D+S europe AG (ISIN: ...
European Capital Financial Services Limited
Madrid, Spain (ots/PRNewswire) - European Capital Financial Services Limited ("European Capital") announced today the opening of its Madrid office, which will be in operation pending the approval of the Financial Services Authority (FSA) and La Comision Nacional del Mercado de Valores (CNMV). The office will concentrate on mezzanine investments, while also providing flexible financing for the Spanish market. ...
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. Plant Openings 09.07.2007 Basel/Zurich, 9 July 2007 - The Swiss financial services industry is about to welcome a newcomer: a bank dedicated to providing clients with investment and savings ...
University of Massachusetts Medical School
Worcester, Massachusetts (ots/PRNewswire) - - ENDORSE Global Findings Highlight the Need to Urgently Implement Hospital-Wide Strategies to Optimize VTE Management: Systematically Assess Patient Risk for VTE and Provide Appropriate prophylaxis to Prevent VTE Venous thromboembolism (VTE) risk is high among ...
Zurich (ots) - The Board of Directors and the Executive Board wish to comment on the planned control by the von Finck group of shareholders. We kindly invite you to our media conference of Today, Tuesday, 3 July 2007, 10.30 am, at the Hyatt Park Hotel Zurich Beethoven-Strasse 21, 8002 Zurich Registration is not necessary. We are looking forward to your participation. Yours sincerely, Von Roll Holding AG Oskar K. ...
ots.CorporateNews transmitted by euro adhoc. The issuer is responsible for the content of this announcement. technology/important product certificate Möglingen (euro adhoc) - Moeglingen, 27th June, 2007. USU´s product suite Valuemation has been officially certified as ITIL compatible by Pink Elephant, an ...
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. annual report 26.06.2007 Krems a. d. Donau, June 27, 2007. In spite of a difficult market situation, Eybl International AG, which manufactures components for automotive interiors and is ...
Meinl Airports International Ltd.
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. Company Information 22.06.2007 Mr. Roman Himmler, Chairman of Meinl Airport Managers Ltd. announced today the formation of a strategic partnership between Airport Design and ...
Milan, Italy (ots/PRNewswire) - - For non-US Healthcare Media Today AMADEO, one of the first studies to compare the protective potential of two angiotensin receptor blockers in hypertensive patients with diabetic nephropathy, was presented at the European Society of Hypertension, Milan. The results from ...
Milan, Italy (ots/PRNewswire) - - For non-US Healthcare Media - Results From Two Large, Multinational, Practice-Based Observational Studies in Blood Pressure New data announced today at the Annual European Society of Hypertension (ESH) show that measuring blood pressure in a doctor's office alone does ...
SW Umwelttechnik Stoiser & Wolschner AG
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. 15.06.2007 Stock exchange announcement: 15 June 2007 SW Umwelttechnik disposes of property in Budapest Framework agreement for sale of 6 hectare (ha) property in Budapest signed E3.6 million ...
Copenhagen, Denmark (ots/PRNewswire) - - Summary: Genmab has Initiated a Phase II Study of Ofatumumab in Combination With CHOP as Front Line Treatment of Follicular NHL. Genmab A/S (CSE: GEN) announced today it has initiated a Phase II study of ofatumumab (HuMax-CD20(R)) in combination with cyclophosphamide, doxorubicin, vincristine and prednisone (CHOP) in patients with previously untreated follicular ...
Notification of voting rights transmitted by euro adhoc. The issuer is responsible for the content of this announcement. Person/company obliged to make the notification: Name: Prudential plc. Place: London State: United Kingdom Company data: Name: ElringKlinger AG Address: Max Eyth Straße 2, ...
Anti-Tumor Necrosis Factor (TNF) Therapy in Inadequately Responding Rheumatoid Arthritis Patients Barcelona (ots) - According to a new study, it is possible to safely switch directly to ORENCIA® from anti-TNF therapy in rheumatoid arthritis patients who have had an inadequate response to anti-TNF therapy. The results were announced today by Bristol-Myers ...
Vancouver, Canada (ots/PRNewswire) - Mawson Resources Limited ("Mawson") TSXv - MAW; Frankfurt - MRY. Michael Hudson, President & CEO, announces results from additional drill holes completed by Mawson at its Kronotorpet uranium - rare earth element (REE) prospect at the Company's Tasjo project in northwestern Sweden. Results are available for a further 19 drill holes (KRODD06020 to KRODD07038) of a 53-drill hole ...
Oss, The Netherlands (ots/PRNewswire) - Sugammadex - the novel selective relaxant binding agent (SRBA) being developed by Organon, the human healthcare business unit of Akzo Nobel - demonstrated in a Phase III pivotal trial a 9-12 times faster reversal of neuromuscular blockade as compared to neostigmine, without ...
Tanzanian Royalty Exploration Corporation
Vancouver, Canada (ots/PRNewswire) - Tanzanian Royalty (TSX: TNX, AMEX: TRE) is pleased to announce that a Phase 2 Reverse Circulation (RC) drilling program has confirmed the presence of two previously interpreted reef (vein) systems along with high grade gold values at its Kigosi Project in the Lake Victoria ...
New control technique Nordex AP applied for international patents ots.CorporateNews transmitted by euro adhoc. The issuer is responsible for the content of this announcement. new product Norderstedt (euro adhoc) - The date is set for the beginning of June 2007, when the first N90/2500 HS is due to go on grid in North America. In Hewitt, Minnesota, one of the most powerful turbines in the USA will then be ...
Chicago (ots/PRNewswire) - - Study Highlights Quality-of-Life Data ALIMTA(R) (pemetrexed for injection) showed additional utility in the treatment of the most diagnosed type of cancer(i), according to data presented today at the 43rd Annual Meeting of the American Society of Clinical Oncology (ASCO). ...
Chicago, Illinois (ots/PRNewswire) - - One Year Results From the ARIBON Study Presented at ASCO 2007 Bondronat(R) (ibandronic acid) has been shown to prevent bone loss caused by anastrozole in post-menopausal women given adjuvant therapy for early breast cancer according to results from the ARIBON ...
Chicago (ots/PRNewswire) - - Five Phase III Early-Stage Breast Cancer Studies Underway With GEMZAR GEMZAR(R) (gemcitabine HC1 for injection), approved in combination with paclitaxel (Taxol(R)) in the first-line, post-surgical treatment of metastatic breast cancer, was the subject of a study ...
Toronto, Canada (ots/PRNewswire) - - Not for Distribution to U.S. Newswire Services or for Dissemination in the U.S - Indicated Mineral Resources Increase 76% in West Zone Starfield Resources Inc. (TSX: SRU : OTCBB: SRFDF) today released a summary of its newly compiled National Instrument 43-101 2007 mineral resource for its Ferguson Lake property in Nunavut, Canada. The document shows an indicated ...
Warimpex Finanz- und Beteiligungs AG
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. 3-month report 30.05.2007 . Revenues increased by 69% . EBITDA adjusted for sales of subsidiaries up by 50% (non-adjusted figure + 228%) . Sale of an office building in Prague . Successful ...
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. 30.05.2007 Graz, 30 May 2007. International Andritz Group received major orders for chemical, recovery, and pulp drying systems from renowned pulp producers in Spain and Portugal totalling ...
- SUPERVISORY AND EXECUTIVE BOARDS PROPOSALS ADOPTED BY A LARGE MAJORITY - 2006 DIVIDEND RAISED TO 2.00 PER SHARE, PLUS A SPECIAL BONUS OF 0.50 - WACKERS GROWTH CONTINUES IN Q1 2007 - FULL-YEAR SALES INCREASE EXPECTED TO EXCEED 10 PERCENT, WITH A HIGHER EBITDA MARGIN THAN LAST YEAR ots.CorporateNews transmitted by euro adhoc. The issuer is responsible ...